Market Research Logo

US Market Report for Continuous Glucose Monitoring 2017 - MedCore

US Market Report for Continuous Glucose Monitoring 2017 - MedCore

The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market was the personal CGM segment. Growth is expected to continue over the forecast period and will be driven by favorable reimbursement, technological innovation and increased uptake of personal CGM among type 1 diabetics and insulin-dependent type 2 diabetics. Professional CGM is typically used in retrospective sessions initiated by physicians, during which a patient wears a CGM sensor for several days to a week, but is ‘blinded’ to the real-time CGM data and must adhere to frequent self-monitoring of blood glucose (SMBG) using traditional blood glucose meters. Additionally, the patient must maintain a record of their daily dietary intake and activity during the time that the sensor is worn. At the end of the session, the patient returns to their physician to remove the sensor and retrospectively analyze the glucose data that was collected. The ‘blinded’ aspect of professional CGM allows physicians to more easily assess their patient’s behavior because their actions are not influenced by ‘real-time’ glucose data, as is the case with personal CGM products.

Continuous glucose monitoring (CGM) allows for a more accurate reading of how blood glucose levels fluctuate throughout the day by measuring interstitial glucose levels on a continuous basis and estimating blood glucose levels based on these readings. A CGM system is typically made up of three components: a glucose sensor, transmitter and receiver. The sensor is inserted under the skin into the interstitial fluid and held with an adhesive. Sensors are typically sold in groups of four and are labeled for six to seven days of use, depending on the manufacturer. A transmitter takes the glucose reading from the sensor and wirelessly sends it to a small, hand-held receiver. If glucose levels are too low or high, the receiver warns the patient. Some manufacturers have even built-in a threshold audible alarm as a fixed safety feature when the patient approaches levels below 55 mg/dL, at which point the patient is still interactive but severely hypoglycemic.


EXECUTIVE SUMMARY
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 INTRODUCTION
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
CONTINUOUS GLUCOSE MONITORING MARKET
3.1 INTRODUCTION
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Total Personal Continuous Glucose Monitoring Market
3.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
3.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
3.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
3.3.2 Total Professional Continuous Glucose Monitoring Market
3.3.2.1 Professional Continuous Glucose Monitoring System Market
3.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
3.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
3.3.3 Emerging Markets: Non-Invasive CGM
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 – 2023
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023
Chart 3 1: Continuous Glucose Monitoring Market by Segment, U.S., 2013 – 2023
Chart 3 2: Continuous Glucose Monitoring Market Breakdown, U.S., 2016
Chart 3 3: Continuous Glucose Monitoring Market Breakdown, U.S.,2023
Chart 3 4: Total Personal Continuous Glucose Monitoring Market by Segment, U.S., 2013 – 2023
Chart 3 5: Total Personal Continuous Glucose Monitoring Market Breakdown, U.S., 2016
Chart 3 6: Total Personal Continuous Glucose Monitoring Market Breakdown, U.S.,2023
Chart 3 7: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2013 – 2023
Chart 3 8: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2013 – 2023
Chart 3 9: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2013 – 2023
Chart 3 10: Total Professional Continuous Glucose Monitoring Market by Segment, U.S., 2013 – 2023
Chart 3 11: Total Professional Continuous Glucose Monitoring Market Breakdown, U.S., 2016
Chart 3 12: Total Professional Continuous Glucose Monitoring Market Breakdown, U.S.,2023
Chart 3 13: Professional Continuous Glucose Monitoring System Market, U.S., 2013 – 2023
Chart 3 14: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2013 – 2023
Chart 3 15: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2013 – 2023
Chart 3 16: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2016
List of Figures
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 – 2016
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016
Figure 1 8: Procedure Codes Investigated, U.S., 2016
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2)
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2)
Figure 1 11: Key Report Updates
Figure 1 12: Version History
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016
Figure 3 1: Continuous Glucose Monitoring Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 3 2: Total Personal Continuous Glucose Monitoring Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 3 3: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2013 – 2023
Figure 3 4: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2013 – 2023
Figure 3 5: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2013 – 2023
Figure 3 6: Total Professional Continuous Glucose Monitoring Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 3 7: Professional Continuous Glucose Monitoring System Market, U.S., 2013 – 2023
Figure 3 8: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2013 – 2023
Figure 3 9: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2013 – 2023
Figure 3 10: Drivers and Limiters, Continuous Glucose Monitoring Market, U.S., 2016
Figure 3 11: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report